ClearID
Empowering Precision Genomic Testing for Personalized Cancer Care
ClearID was launched by Cynvenio Biosystems to provide genomic testing solutions to physicians and their patients.
CHALLENGE
Cynvenio recognized the need to establish ClearID as a distinct brand and expand its offerings. To achieve this, they sought to establish a strong brand identity for ClearID, develop a web presence, and create targeted materials for physicians and patients. They required a wide range of creative services to support these efforts.
SOLUTION
This collaboration involved a full suite of solutions, including:
Marketing & Sales Collateral: ClearID's value proposition was effectively communicated through compelling materials, showcasing the precision genomic testing capabilities and the benefits for physicians and patients.
Communications: ClearID developed clear and engaging communication strategies to reach physicians and patients, highlighting the importance of their tests for personalized cancer care.
Packaging Design: Branded ClearID test kits were developed, ensuring a professional and user-friendly experience.
Presentations / Pitch Decks: Visually impactful presentations and pitch decks effectively conveyed ClearID's unique offerings, securing partnerships and funding opportunities.
Customer Support Materials: Comprehensive customer support materials were produced to provide clear instructions and information to guide physicians, labs, and patients through the testing process.
Visual Communications: Visual communication techniques enhanced understanding of complex genomic concepts and test results, making them more accessible to physicians and patients.
Report Development: ClearID's test results were presented in clear report designs, facilitating informed decision-making.
RESULTS
The comprehensive suite of creative services enabled ClearID to establish a strong brand and successfully launch liquid biopsy-based tests for various cancer types.
HIGHLIGHTS
Launched a strong, standalone sub-brand
Developed targeted communication programs designed to educate the market and built trust for new testing approaches
Gained industry traction for novel cancer tests
